MX9710472A - 4-aril-fenilalquil-1,2,3,6-tetrahidropiridinas que tienen una actividad neurotrofica y neuroprotectora. - Google Patents
4-aril-fenilalquil-1,2,3,6-tetrahidropiridinas que tienen una actividad neurotrofica y neuroprotectora.Info
- Publication number
- MX9710472A MX9710472A MX9710472A MX9710472A MX9710472A MX 9710472 A MX9710472 A MX 9710472A MX 9710472 A MX9710472 A MX 9710472A MX 9710472 A MX9710472 A MX 9710472A MX 9710472 A MX9710472 A MX 9710472A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- group
- alkoxyl
- alkoxycarbonyl
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere a los compuestos de formula (I): en la cual Y representa -CH- o -N-; R1 representa el hidrogeno, un halogeno, un grupo CF3, (C3-C4)alquilo o (C1-C4)alcoxilo; R2 representa el hidrogeno, un halogeno, un hidroxilo, un grupo CF3 (C3-C4)-alquilo o (C1-C4)alcoxilo; R3 y R4 representan cada uno el hidrogeno o un (C1-C3) alquilo; X representa (a) un (C3-C6)alquilo; un (C3-C6)alcoxilo; un (C3-7)carboxialquilo; un (C1-C4)alcoxicarbonil (C3-C6)alquilo; un (C3-C7)carboxialquilo; o un (C1-C4)alcoxicarbonil (C3-C6)alcoxilo; (b) un radical escogido entre un (C3-C7)cicloalquilo, (C3-C7)cicloalquiloxi, (C3-C7)cicloalquimetilo, (C3-C7)cicloalquilamino y ciclohexefinilo, dicho radical puede ser sustituido por un halogeno, hidroxi, (C1-C4)alcoxi, carboxi, (C1-C4)alcoxicarbonilo, amino, mono- o di-(C1-C4)alquilamino; o (c) un grupo escogido entre un fenilo, fenoxi, penilamino, N- (C1-C3)alquil-fenilamino, fenilmetilo, feniletilo, fenilcarbonilo, feniltio, fenilsulfonilo, fenilsulfinilo o stirile, dicho grupo puede ser mono-o polisustituído sobre el grupo fenilo por un halogeno, CF3, (C1-C4)alquilo, (C1-C4)alcoxi, ciano, amino, mono- o di- (C1-C4)-alquilamino, (C1-C4)acilamino, carboxi, (C1-C4)alcoxicarbonilo, amino-carbonilo, mono- o di- (C1-C4)alquilaminocarbonilo, amino(C1-C4)-alquilo; hidroxi (C1-C4) alquilo o halogeno (C1-C4) alquilo; así que sus sales y solventes y sus sales de amonio cuaternarias, un procedimiento para su preparacion y las composiciones farmacéuticas que lo contienen. Esos compuestos tienen una actividad neurotrofica y neuroprotectora.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9507760 | 1995-06-28 | ||
| FR95/07760 | 1995-06-28 | ||
| FR9507760A FR2736053B1 (fr) | 1995-06-28 | 1995-06-28 | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
| PCT/FR1996/000995 WO1997001536A1 (fr) | 1995-06-28 | 1996-06-26 | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines ayant une activite neurotrophique et neuroprotectrice |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9710472A true MX9710472A (es) | 1998-03-31 |
| MXPA97010472A MXPA97010472A (es) | 1998-10-15 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2312B1 (en) | 4-Aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity. | |
| IL111245A0 (en) | Cyclic amides and fungicidal compositions containing them | |
| AU636012B2 (en) | N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran )carboxamide derivatives | |
| NO996108L (no) | 9-oksinerytromycinderivater | |
| AU2003278296A1 (en) | Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same | |
| TW200503704A (en) | N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines | |
| MY132009A (en) | Pharmaceutical compounds. | |
| AU591165B2 (en) | Angiotensin converting enzyme inhibitors | |
| ATE285403T1 (de) | Verfahren zur herstellung von n-((4- phenyl)methylphenyl)piperazinen | |
| EP0300882A3 (en) | Novel 5-aminomethylene-2,4-imidazolidinediones and 5-aminomethylene-2-thionoimidazolidine-4-ones | |
| NZ236293A (en) | 1-(alkyl or alkoxyalkyl)-4-phenyl piperidine-4-carboxylic acid amide derivatives; preparatory processes and pharmaceutical compositions | |
| MY120461A (en) | Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia. | |
| UA41928C2 (uk) | Похідні оксазолідину, спосіб їх одержання, фармацевтична композиція та спосіб її одержання, спосіб лікування захворювань | |
| MY102578A (en) | Substituted 1h-imidazoles | |
| NZ336033A (en) | 4-substituted 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease | |
| RU99115083A (ru) | 1-фенилалкил-1,2,3,6-тетрагидропиридины для лечения болезни альцгеймера |